ENPP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Based on expression of CD203c on mature and immature basophils throughout all stages of differentiation, CD203c is recommended as a pan-basophil marker in these patients and as a potential new flow-marker supporting prognostication in CML.